FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313593608> ?p ?o ?g. }

• W4313593608 endingPage "840" @default.
• W4313593608 startingPage "831" @default.
• W4313593608 abstract "Background Melanoma survival literature predominantly represents patients >65 years of age. Study of younger patients may reveal potential age-group-specific differences in survival outcome. Objective Identify factors associated with differences in melanoma survival in 2 age groups, adolescents and young adults (AYAs; ages 15-39) and older adults (ages 40-64). Methods This population-based registry study included all cases (n = 81,597) of cutaneous melanoma diagnosed at ages 15 to 64 from 2004 to 2015 in California. Age-group-specific multivariable Cox hazard regressions were used. Results In the adjusted, age-group-specific models, AYA patients with stage IV melanoma had worse survival (hazard ratio: 20.39, 95% CI: 13.30-31.20) than was observed among older adults (hazard ratio: 10.79, 95% CI: 9.33-12.48). Thicker tumors and public insurance were also associated with worse survival for AYAs than observed in models for older adults. AYAs experienced better survival when detected at earlier stages. Limitations Registry data do not routinely collect behavioral information or family history of melanoma. Conclusions Survival was much worse for AYAs with stage IV melanoma than observed among older adults. To improve AYA survival, early melanoma detection is critical. Greater awareness, suspicion, and screening for AYA melanoma may disrupt delays in diagnosis and reduce the excess burden of mortality from stage IV melanoma in young patients. Melanoma survival literature predominantly represents patients >65 years of age. Study of younger patients may reveal potential age-group-specific differences in survival outcome. Identify factors associated with differences in melanoma survival in 2 age groups, adolescents and young adults (AYAs; ages 15-39) and older adults (ages 40-64). This population-based registry study included all cases (n = 81,597) of cutaneous melanoma diagnosed at ages 15 to 64 from 2004 to 2015 in California. Age-group-specific multivariable Cox hazard regressions were used. In the adjusted, age-group-specific models, AYA patients with stage IV melanoma had worse survival (hazard ratio: 20.39, 95% CI: 13.30-31.20) than was observed among older adults (hazard ratio: 10.79, 95% CI: 9.33-12.48). Thicker tumors and public insurance were also associated with worse survival for AYAs than observed in models for older adults. AYAs experienced better survival when detected at earlier stages. Registry data do not routinely collect behavioral information or family history of melanoma. Survival was much worse for AYAs with stage IV melanoma than observed among older adults. To improve AYA survival, early melanoma detection is critical. Greater awareness, suspicion, and screening for AYA melanoma may disrupt delays in diagnosis and reduce the excess burden of mortality from stage IV melanoma in young patients." @default.
• W4313593608 created "2023-01-06" @default.
• W4313593608 creator A5017377056 @default.
• W4313593608 creator A5017659135 @default.
• W4313593608 creator A5027919957 @default.
• W4313593608 creator A5028968904 @default.
• W4313593608 creator A5052358135 @default.
• W4313593608 creator A5076276085 @default.
• W4313593608 creator A5089248140 @default.
• W4313593608 creator A5090789371 @default.
• W4313593608 date "2023-04-01" @default.
• W4313593608 modified "2023-10-15" @default.
• W4313593608 title "Melanoma survival by age group: Population-based disparities for adolescent and young adult patients by stage, tumor thickness, and insurance type" @default.
• W4313593608 cites W1591554783 @default.
• W4313593608 cites W1978037194 @default.
• W4313593608 cites W1981096529 @default.
• W4313593608 cites W1997022471 @default.
• W4313593608 cites W2010976574 @default.
• W4313593608 cites W2030982201 @default.
• W4313593608 cites W2042475475 @default.
• W4313593608 cites W2043259769 @default.
• W4313593608 cites W2047610429 @default.
• W4313593608 cites W2069439351 @default.
• W4313593608 cites W2096919143 @default.
• W4313593608 cites W2109078042 @default.
• W4313593608 cites W2110108440 @default.
• W4313593608 cites W2111108112 @default.
• W4313593608 cites W2124896191 @default.
• W4313593608 cites W2127630510 @default.
• W4313593608 cites W2132875192 @default.
• W4313593608 cites W2149103312 @default.
• W4313593608 cites W2158140204 @default.
• W4313593608 cites W2169330674 @default.
• W4313593608 cites W2252856156 @default.
• W4313593608 cites W2263279668 @default.
• W4313593608 cites W2274595087 @default.
• W4313593608 cites W2293074300 @default.
• W4313593608 cites W2296573224 @default.
• W4313593608 cites W2298617406 @default.
• W4313593608 cites W2323881126 @default.
• W4313593608 cites W2341727896 @default.
• W4313593608 cites W2397763264 @default.
• W4313593608 cites W2409885905 @default.
• W4313593608 cites W2732305016 @default.
• W4313593608 cites W2761060985 @default.
• W4313593608 cites W2762347490 @default.
• W4313593608 cites W2792914890 @default.
• W4313593608 cites W2799397265 @default.
• W4313593608 cites W2801523097 @default.
• W4313593608 cites W2810003925 @default.
• W4313593608 cites W2903006794 @default.
• W4313593608 cites W2911580731 @default.
• W4313593608 cites W2921201783 @default.
• W4313593608 cites W2940910169 @default.
• W4313593608 cites W2983347147 @default.
• W4313593608 cites W3167614629 @default.
• W4313593608 doi "https://doi.org/10.1016/j.jaad.2022.10.063" @default.
• W4313593608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36610687" @default.
• W4313593608 hasPublicationYear "2023" @default.
• W4313593608 type Work @default.
• W4313593608 citedByCount "0" @default.
• W4313593608 crossrefType "journal-article" @default.
• W4313593608 hasAuthorship W4313593608A5017377056 @default.
• W4313593608 hasAuthorship W4313593608A5017659135 @default.
• W4313593608 hasAuthorship W4313593608A5027919957 @default.
• W4313593608 hasAuthorship W4313593608A5028968904 @default.
• W4313593608 hasAuthorship W4313593608A5052358135 @default.
• W4313593608 hasAuthorship W4313593608A5076276085 @default.
• W4313593608 hasAuthorship W4313593608A5089248140 @default.
• W4313593608 hasAuthorship W4313593608A5090789371 @default.
• W4313593608 hasConcept C10515644 @default.
• W4313593608 hasConcept C126322002 @default.
• W4313593608 hasConcept C144024400 @default.
• W4313593608 hasConcept C146357865 @default.
• W4313593608 hasConcept C149923435 @default.
• W4313593608 hasConcept C151730666 @default.
• W4313593608 hasConcept C187212893 @default.
• W4313593608 hasConcept C205545832 @default.
• W4313593608 hasConcept C207103383 @default.
• W4313593608 hasConcept C2776283816 @default.
• W4313593608 hasConcept C2777658100 @default.
• W4313593608 hasConcept C2908647359 @default.
• W4313593608 hasConcept C44249647 @default.
• W4313593608 hasConcept C502942594 @default.
• W4313593608 hasConcept C50382708 @default.
• W4313593608 hasConcept C71924100 @default.
• W4313593608 hasConcept C74909509 @default.
• W4313593608 hasConcept C86803240 @default.
• W4313593608 hasConcept C99454951 @default.
• W4313593608 hasConceptScore W4313593608C10515644 @default.
• W4313593608 hasConceptScore W4313593608C126322002 @default.
• W4313593608 hasConceptScore W4313593608C144024400 @default.
• W4313593608 hasConceptScore W4313593608C146357865 @default.
• W4313593608 hasConceptScore W4313593608C149923435 @default.
• W4313593608 hasConceptScore W4313593608C151730666 @default.
• W4313593608 hasConceptScore W4313593608C187212893 @default.
• W4313593608 hasConceptScore W4313593608C205545832 @default.
• W4313593608 hasConceptScore W4313593608C207103383 @default.

• next